Systematic approach to hair loss in women

被引:34
作者
Trueeb, Ralph M. [1 ]
机构
[1] Univ Spital Zurich, Dermatol Klin, Dept Dermatol, CH-8901 Zurich, Switzerland
来源
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2010年 / 8卷 / 04期
关键词
women; telogen effluvium; seasonality; minoxidil; oral supplementation; psychological counseling; SERUM FERRITIN LEVELS; IRON-DEFICIENCY; ANDROGENETIC ALOPECIA; CYPROTERONE-ACETATE; TELOGEN-EFFLUVIUM; DIFFUSE ALOPECIA; GROWTH; ASSOCIATION; SCALP;
D O I
10.1111/j.1610-0387.2010.07261.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P>Diffuse hair loss is a common complaint and cause of significant emotional distress particularly in women. The best way to alleviate the anxiety is to effectively treat the hair loss. It is paramount to address the symptom systematically. In addition to its psychological impact, hair loss may be a manifestation of a more general medical problem. The diagnosis can be established with a detailed patient history focussing on chronology of events, examination of the scalp and pattern of hair loss, a pull test with examination of bulbs of shed hairs, trichoscopy, and few pertinent screening blood tests. In selected cases a scalp biopsy may be required. The most important differential diagnoses include acute and chronic telogen effluvium, female pattern hair loss, and diffuse alopecia areata. Occasionally, patients seeking advice are not necessarily losing hair. In the absence of convincing evidence of hair loss, they are suffering of psychogenic pseudoeffluvium, and thought should be given to an underlying psychological disorder. Once the diagnosis is established, treatment appropriate for that diagnosis is likely to control the hair loss. Finally, appropriate psychological support and education about the basics of the hair cycle, and why considerable patience is required for effective cosmetic recovery, are essential to help limit patient anxiety.
引用
收藏
页码:284 / 296
页数:13
相关论文
共 35 条
  • [1] AHRENS J, 1994, THERAPIEWOCHE SCHWEI, V10, P551
  • [2] Does tissue iron status have a role in female alopecia?
    Aydingöz, IE
    Ferhanoglu, B
    Güney, O
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 1999, 13 (01) : 65 - 67
  • [3] No association between serum ferritin levels 110 μg/l and hair loss activity in women
    Bregy, Amade
    Trueeb, Ralph M.
    [J]. DERMATOLOGY, 2008, 217 (01) : 1 - 6
  • [4] BUDDE J, 1993, HAUTARZT, V44, P380
  • [5] Courtois M, 1996, BRIT J DERMATOL, V134, P47, DOI 10.1111/j.1365-2133.1996.tb07839.x
  • [6] Chemoprevention of smoke-induced alopecia in mice by oral administration of L-cystine and vitamin B6
    D'Agostini, Francesco
    Fiallo, Paolo
    Pennisi, Tanya M.
    De Flora, Silvio
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2007, 46 (03) : 189 - 198
  • [7] Gehring W, 2000, Z HAUTKRANKHEITEN, V75, P419
  • [8] Quantitating hair loss in women: A critical approach
    Guarrera, M
    Semino, MT
    Rebora, A
    [J]. DERMATOLOGY, 1997, 194 (01) : 12 - 16
  • [9] DIFFUSE CYCLIC HAIR LOSS IN WOMEN
    GUY, WB
    EDMUNDSON, WF
    [J]. ARCHIVES OF DERMATOLOGY, 1960, 81 (02) : 205 - 207
  • [10] HARD S, 1963, ACTA DERM-VENEREOL, V43, P562